Zhitong Finance App News, Gaoshi Healthcare (02407) announced that the Group is expected to record a net profit of about RMB 13.9 million to RMB 16.7 million for the six months ending June 30, 2026. Compared with the net profit of about RMB 35.9 million for the six months ending June 30, 2025, a decrease of about 53.5% to 61.3%.

According to the information currently available to the board of directors, the board of directors believes that the decline in net profit is mainly due to: (i) The Group's revenue forecast for the six months ending June 30, 2026 is about RMB 542 million to RMB 649 million, a decrease of about 0.7% to 17.1% from the six months ending June 30, 2025 of approximately 0.7% to 17.1%. This is due to the combined effects of multiple adverse factors such as changes in the market demand structure guided by national policies and the termination of overseas Feibai product agency cooperation within the six months ending June 30, 2026. Revenue from products distributed by the Group declined; and (ii) due to exchange rate fluctuations, exchange losses for the six months ended June 30, 2026 increased by approximately RMB7.8 million to RMB9.8 million compared to the six-month forecast for the six-month period ending June 30, 2025.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.